Board Members

The Board oversees the performance of the organisation and of each of the co-ordinating Committees; Professional Development, Conference, and Advocacy. Upcoming vacancies on the PraxisAuril Board are notified to PraxisAuril members via the PraxisAuril website, NewsUpdate and Directors’ Jisclist. Current vacancies

Current Board members are:

Chair

Board Member Image

Dr. Angela Kukula RTTP

Director of Enterprise
Institute of Cancer Research

Angela Kukula is Director of Enterprise at the Institute of Cancer Research in London. The Enterprise Unit manages all intellectual property and commercial issues at The Institute including arranging collaborations with pharmaceutical and biotechnology companies, negotiating clinical trial agreements, patenting, licensing and the formation of spin-out companies. Angela has a BA in Biochemistry from Oxford University and PhD in Immunology and Genetics from the Institute of Child Health University of London. She also has an MBA specialising in technology management and an LLM in commercial law.

After a post-doc position at Osaka University in Japan, Angela spent a number of years managing international collaborative R&D programmes in the Pharmaceutical industry, before moving into technology transfer. Prior to joining ICR, Angela was Head of IP and Commercialisation at Aston University where she was responsible for all of the University's technology transfer activities.

Angela has managed portfolios of over 100 patent families and has concluded a large number of licensing and commercialisation deals. She has also been instrumental in the establishment of several spin-out companies. She regularly lectures on innovation and intellectual property matters and sits on a number of national and international research and exploitation bodies.

Vice Chair

Board Member Image

Sean Fielding RTTP

Director of Innovation, Impact & Business
University of Exeter

Sean Fielding / Director of Innovation Impact and Business, University of Exeter

Sean’s team handles the University of Exeter's support for collaboration with external partners whether for research, education or commercial business such as spin-outs and licensing. He is also responsible for strategic alliances, regional economic development and the generation of impact from the University’s research. Sean is chair of the SETsquared Management Board. He is a former member of the Board of the Heart of the South West Local Enterprise Partnership and the European Association for Knowledge Transfer. He is a Director for The Exeter Science Park.

Immediate Past Chair

Board Member Image

Dr. Martin Davies

Director of Business and Innovation Partnerships
University College London

Martin leads the Business and Innovation Partnerships team at UCL. The team works with large firms and SMEs in key sectors to forge major, institutional-level business partnerships that will extend UCL’s research into new areas and lead to new innovations with industry.

Martin has spent more than 25 years working on business-university collaborations as a researcher, academic, innovation specialist, and director of university research and enterprise teams. He's also been involved in business development in health and biosciences, business incubation, managing major economic development projects in London and setting up his own spin out companies in the biomedical sciences sector.

Martin is a PraxisAuril board member (immediate Past Chair), and previously Chair of, AURIL - the Association for University Research and Industry Links. He originally trained in chemistry and has a first degree and PhD from Imperial College London.

Board Member

Board Member Image

Simon Bond

Innovation Director
SETsquared

Experienced Director of business incubation, university enterprise & research commercialisation, specialising in business development strategies for innovation-intensive companies.

As a proactive member of the UK’s innovation community I serve on the Board of PraxisAuril, as Vice Chair of Low Carbon South West CIC, and as a member of the West of England Combined authority's Business Advisory Board.

Board Member

Board Member Image

Dr. Phil Clare RTTP

Deputy Director, Research Services
University of Oxford

Phil is Chair of PraxisAuril's Advocacy Committee. His main focus of responsibility as Associate Director, Research Services and Head of Knowledge Exchanges at the University of Oxford includes research contracts, intellectual property management and industry links. He has been a member of the PraxisUnico Board for several years, and before that spent six years on the committee of ARMA, the Association of Research Managers and Administrators.

He used to be a chemist but a year after completing his PhD accidentally became an administrator. Since leaving science, he has been working in research administration and innovation at the Universities of Bath, Bournemouth and Oxford, and also worked for the UK Research Office in Brussels.

He is a director of Fluvial Innovations Ltd, a small start-up, and the Oxford Football league, a local social enterprise. He has just completed an executive MBA at the Saïd Business School at the University of Oxford. He believes passionately in the importance of research in universities to the economic and intellectual life of any country, and the role of research support and technology transfer offices in supporting that contribution.

Board Member

Board Member Image

Tony Hickson RTTP

Managing Director
Imperial Innovations Ltd

Tony Hickson BSc, MBA, CLP, RTTP is Managing Director of the Technology Transfer team and an Executive Director on the board of Imperial Innovations Group PLC. Tony is responsible for intellectual property sourcing, licensing and spin-out creation for technologies arising from Imperial College London. Prior to joining the company in 2002, Tony had acquired 15 years of commercial and business development experience in bioscience companies including Wellcome Group, Murex Biotech, Abbott Laboratories and Kalibrant Limited. He has been a board director or observer for a number of start-up companies including Emcision, Polytherics (now Abzena) and Acublate Ltd, and was instrumental in the creation of companies such as Thiakis (sold to Wyeth, now Pfizer, in 2008), Respivert (sold to J&J in 2010), Circassia (floated on LSE in 2014) and Cell Medica (in advanced clinical studies). Tony is a Certified Licensing Professional, a board director of PraxisUnico and until recently acted as Chairman of the Intellectual Property Board of the European Institute of Technology Climate Change KIC.

Board Member

Board Member Image

Bryn Jones

Head of Knowledge Exchange
Bangor University

Bryn is the Head of the Knowledge Exchange at Bangor University where he leads the team delivering business - academic collaborations. Based in the Research and Enterprise Office, Bryn has over 15 years’ experience of implementing a range of collaborative programmes including award winning KTPs and the ESF funded Knowledge Economy Skills Scholarship Programme (KESS), which supports collaborative PhD and Masters with SMEs in the West Wales and Valleys convergence region.

In his current role, Bryn is responsible for providing a ͚front door͛ to business enquires at Bangor across a broad portfolio of activities encompassing enterprise, innovation, regional development and skills. Bangor͛s approach is based on ͚Putting Knowledge to Work͛, with a diverse range of private, public and third sector partners and delivering support focused on inspiring innovation, improving performance and promoting sustainability.

He previously sat on the Council of AURIL and is also a former chair of the Welsh Industrial Liaison Officers Group (WILOs). A fluent Welsh speaker he received an Exec MBA from Bangor University in 2012.

Board Member

Board Member Image

Dr. Alistair McDermott

Chief Executive Officer
Imperial Consultants

Alistair McDermott is CEO of Imperial Consultants, the commercial gateway to the academic expertise of Imperial College London, where he is responsible for increasing the number of academics undertaking consultancy projects at Imperial College whilst maintaining the university consulting service as a self-sustaining business. Alistair has worked for a number of universities and Research Councils supporting those institutions in expanding their research and commercial portfolios. He has been involved in the development of large national and international scientific research facilities and creating industry led research programmes. He has led regional businesses support initiatives, set up start-up centres and created joint ventures. Alistair has a degree and PhD in Material Science from the University of Sheffield and an MBA from the Open University.

Board Member

Board Member Image

Mrs. Jennie Shorley

Associate Head - RKE
Manchester Metropolitan University

Jennie joined the Centre for Enterprise in July 2010. As Head of Bids and Partnerships Jennie has led the bids team to secure £3M of funding for business growth and innovation support for small firms, as well as successful research council bids to the ESRC, AHRC and EPSRC. As a senior member of the management team she represents MMU and the Centre for Enterprise throughout the UK and Europe.
Jennie led the award-winning £2.5M ERDF-funded Knowledge Action Network project across the North West. This flagship project worked with 214 small companies across the North West, supporting these firms to create 71 and safeguard 61 jobs.
Jennie leads partnerships across Europe for the Centre for Enterprise, including heading the £0.5M Leonardo Transfer of Innovation Programme with 10 EU business and university partners. She currently leads MMU’s involvement in 3 Erasmus+ programmes. She has strong university and business connections in Croatia, France, Poland, Finland, Spain, The Netherlands and Germany.

Board Member

Board Member Image

Dr. Iain Thomas RTTP

Head of Life Sciences
Cambridge Enterprise Ltd

Iain is Head of Cambridge Enterprise’s Life Sciences team at the University of Cambridge where he and his team work in fields as diverse as therapeutics, diagnostics, biofuels, IVF, epigenetics and agritech. CE’s portfolio of products includes alemtuzumab (Sanofi), breast cancer markers (Brevagen) and mouse touch screen chambers (Campden Instruments). Recent spin-outs include Morphogenix, Mission Therapeutics, Cambridge Epigenetix, XO1 Therapeutics (sold to Janssen), Z-factor, Phoremost, and Storm Therapeutics. Iain led discussions with GSK in respect of the University of Cambridge–GSK open innovation drug discovery initiative based at the SBC and was the Cambridge lead for the Apollo Therapeutics Fund. Iain has been an active trainer for Praxis Courses since 2004.